Estonia’s digital health DNA: Trust, data, and biotech in focus
With just 1.3 million residents, Estonia’s digital footprint far exceeds its size. When Barack Obama visited Tallinn in 2014, he…
All articles by Catherine Longworth
Catherine Longworth
@MedtechCate
Catherine Longworth is the Editor for Medical Device Network, covering developments across the medical technology and health tech industry. An experienced writer, Catherine has covered the industry since 2016 and has a background in biomedical science and journalism. Her previous experience includes reporting for Medtech Insight (Citeline, formerly Informa Pharma Intelligence) and Bioworld (Clarivate).
-
-
Navigating regulatory change in APAC: Insights from the upcoming BioSecure Act Webinar
The regulatory landscape across the Asia-Pacific (APAC) region is evolving rapidly, and pharmaceutical companies must adapt to maintain compliance, mitigate…
-
Europe’s cannabis pharmaceuticals market matures amid cautious investment
Europe’s cannabis pharmaceutical market is far from a gold rush, yet it is emerging as one of the more strategic…
-
Synthetic rescue: Insmed explores a new frontier in genetic therapeutics
Nestled on the southern fringe of Cambridge within the Babraham Research Campus, US-based biopharma Insmed is laying the groundwork for…
-
London Biotechnology Show Makes Grand Return to Unveil Cutting-edge Advances in Health & Medicine
The inaugural London Biotechnology Show was a major hit with over 3,000 attendees present at the event, including representatives from…
-
Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025
Big data, Artificial Intelligence (AI), Machine Learning (ML) and other emerging technologies are transforming the pharmaceutical industry right before our…
-
“Leave politics out of healthcare” – controversy swirls around BIOSECURE Act
Members of the biotech industry have voiced concerns about the impact of the BIOSECURE Act, after the bill passed through…